1
|
A novel method for the chaperone aided and efficient production of human proinsulin in the prokaryotic system. J Biotechnol 2022; 346:35-46. [DOI: 10.1016/j.jbiotec.2022.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Revised: 12/27/2021] [Accepted: 01/13/2022] [Indexed: 02/07/2023]
|
2
|
Siew YY, Zhang W. Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies. BIORESOUR BIOPROCESS 2021; 8:65. [PMID: 34336550 PMCID: PMC8313369 DOI: 10.1186/s40643-021-00419-w] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 07/20/2021] [Indexed: 11/10/2022] Open
Abstract
The Global Diabetes Compact was launched by the World Health Organization in April 2021 with one of its important goals to increase the accessibility and affordability of life-saving medicine-insulin. The rising prevalence of diabetes worldwide is bound to escalate the demand for recombinant insulin therapeutics, and currently, the majority of recombinant insulin therapeutics are produced from E. coli inclusion bodies. Here, a comprehensive review of downstream processing of recombinant human insulin/analogue production from E. coli inclusion bodies is presented. All the critical aspects of downstream processing, starting from proinsulin recovery from inclusion bodies, inclusion body washing, inclusion body solubilization and oxidative sulfitolysis, cyanogen bromide cleavage, buffer exchange, purification by chromatography, pH precipitation and zinc crystallization methods, proinsulin refolding, enzymatic cleavage, and formulation, are explained in this review. Pertinent examples are summarized and the practical aspects of integrating every procedure into a multimodal purification scheme are critically discussed. In the face of increasing global demand for insulin product, there is a pressing need to develop a more efficient and economical production process. The information presented would be insightful to all the manufacturers and stakeholders for the production of human insulins, insulin analogues or biosimilars, as they strive to make further progresses in therapeutic recombinant insulin development and production.
Collapse
Affiliation(s)
- Yin Yin Siew
- Downstream Processing Group, Bioprocessing Technology Institute, Agency for Science, Technology and Research, Singapore, Singapore
| | - Wei Zhang
- Downstream Processing Group, Bioprocessing Technology Institute, Agency for Science, Technology and Research, Singapore, Singapore
| |
Collapse
|
3
|
In vitro refolding with simultaneous purification of recombinant human parathyroid hormone (rhPTH 1–34) from Escherichia coli directed by protein folding size exclusion chromatography (PF-SEC): implication of solution additives and their role on aggregates and renaturation. Anal Bioanal Chem 2015; 408:217-29. [DOI: 10.1007/s00216-015-9097-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2015] [Accepted: 10/01/2015] [Indexed: 11/26/2022]
|
4
|
Zhang R, Zhang L, Li C, Chen B, Li Q, Fang X, Shen Y. Refolding of Recombinant Histidine-Tagged Catalytic Domain of MMP-13 from Escherichia coli with Ion-Exchange Chromatography for Higher Bioactivity. J LIQ CHROMATOGR R T 2015. [DOI: 10.1080/10826076.2014.917669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Ruiying Zhang
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| | - Lu Zhang
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| | - Cong Li
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| | - Bang Chen
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| | - Qing Li
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| | - Xuexun Fang
- b Key Laboratory for Molecular Enzymology & Engineering of Ministry of Education , Jilin University , Chang Chun , P. R. China
| | - Yehua Shen
- a Key Laboratory of Synthetic and Natural Function Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Shaanxi Alcohol Ether and Biomass Energy Engineering Research Center/Director Key Laboratory of Yulin Desert Plants Resources , Northwest University , Xi'an , P. R. China
| |
Collapse
|
5
|
Wang Y, Ren W, Gao D, Wang L, Yang Y, Bai Q. One-step refolding and purification of recombinant human tumor necrosis factor-α (rhTNF-α) using ion-exchange chromatography. Biomed Chromatogr 2014; 29:305-11. [PMID: 24941919 DOI: 10.1002/bmc.3276] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2014] [Revised: 05/12/2014] [Accepted: 05/21/2014] [Indexed: 11/05/2022]
Abstract
Protein refolding is a key step for the production of recombinant proteins, especially at large scales, and usually their yields are very low. Chromatographic-based protein refolding techniques have proven to be superior to conventional dilution refolding methods. High refolding yield can be achieved using these methods compared with dilution refolding of proteins. In this work, recombinant human tumor necrosis factor-α (rhTNF-α) from inclusion bodies expressed in Escherichia coli was renatured with simultaneous purification by ion exchange chromatography with a DEAE Sepharose FF column. Several chromatographic parameters influencing the refolding yield of the denatured/reduced rhTNF-α, such as the urea concentration, pH value and concentration ratio of glutathione/oxidized glutathione in the mobile phase, were investigated in detail. Under optimal conditions, rhTNF-α can be renatured and purified simultaneously within 30 min by one step. Specific bioactivity of 2.18 × 10(8) IU/mg, purity of 95.2% and mass recovery of 76.8% of refolded rhTNF-α were achieved. Compared with the usual dilution method, the ion exchange chromatography method developed here is simple and more effective for rhTNF-α refolding in terms of specific bioactivity and mass recovery.
Collapse
Affiliation(s)
- Yan Wang
- Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, Institute of Modern Separation Science, Key Laboratory of Modern Separation Science in Shaanxi Province, Northwest University, Xi'an, 710069, China
| | | | | | | | | | | |
Collapse
|
6
|
Wang F, Guo J, Bai Q, Wang L. Refolding and purification of recombinant human (Pro)renin receptor fromEscherichia coliby ion exchange chromatography. Biotechnol Prog 2014; 30:864-71. [DOI: 10.1002/btpr.1916] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2013] [Revised: 03/27/2014] [Accepted: 03/29/2014] [Indexed: 11/09/2022]
Affiliation(s)
- Fei Wang
- Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education; Inst. of Modern Separation Science, Key Lab of Modern Separation Science in Shaanxi Province, Northwest University; Xi'an 710069 China
| | - Jinjin Guo
- Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education; Inst. of Modern Separation Science, Key Lab of Modern Separation Science in Shaanxi Province, Northwest University; Xi'an 710069 China
| | - Quan Bai
- Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education; Inst. of Modern Separation Science, Key Lab of Modern Separation Science in Shaanxi Province, Northwest University; Xi'an 710069 China
| | - Lili Wang
- Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education; Inst. of Modern Separation Science, Key Lab of Modern Separation Science in Shaanxi Province, Northwest University; Xi'an 710069 China
| |
Collapse
|
7
|
Wellhoefer M, Sprinzl W, Hahn R, Jungbauer A. Continuous processing of recombinant proteins: Integration of inclusion body solubilization and refolding using simulated moving bed size exclusion chromatography with buffer recycling. J Chromatogr A 2013; 1319:107-17. [DOI: 10.1016/j.chroma.2013.10.039] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2013] [Revised: 10/08/2013] [Accepted: 10/09/2013] [Indexed: 10/26/2022]
|
8
|
Abstract
A method for carrying out protein folding with simultaneous separation by protein folding liquid chromatography (PFLC) is described herein. Furthermore, a two-dimensional chromatographic column, termed a 2D column, which can be independently employed for accomplishing PFLC in either weak cation exchange mode or hydrophobic interaction chromatography mode is reported. The content of this chapter describes the most commonly employed methods and operations of PFLC, such as the use of urea or guanidine hydrochloride as a denaturant with the protein in either the reduced or oxidized state and solving problems caused by the formation of the precipitates during protein folding. The PFLC can be performed using conventional chromatographic columns and a new chromatographic cake. A protocol for fast renaturation with simultaneous purification of inclusion body protein of the recombinant human interferon-gamma to obtain purity ≥95% and high specific bioactivity in a single step and in 1 h is introduced.
Collapse
Affiliation(s)
- Quan Bai
- Key Laboratory of Modern Separation Science in Shaanxi Province, Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, Institute of Modern Separation Science, Northwest University, Xi'an, China.
| | | |
Collapse
|
9
|
Ion-exchange chromatographic protein refolding. J Chromatogr A 2010; 1217:7265-74. [DOI: 10.1016/j.chroma.2010.09.044] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2010] [Revised: 09/03/2010] [Accepted: 09/14/2010] [Indexed: 11/22/2022]
|
10
|
|
11
|
Liquid chromatography of recombinant proteins and protein drugs. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 866:133-53. [DOI: 10.1016/j.jchromb.2008.01.041] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2007] [Revised: 12/17/2007] [Accepted: 01/18/2008] [Indexed: 01/12/2023]
|
12
|
Sahdev S, Khattar SK, Saini KS. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem 2007; 307:249-64. [PMID: 17874175 DOI: 10.1007/s11010-007-9603-6] [Citation(s) in RCA: 254] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2007] [Accepted: 08/27/2007] [Indexed: 12/13/2022]
Abstract
Among the various expression systems employed for the over-production of proteins, bacteria still remains the favorite choice of a Protein Biochemist. However, even today, due to the lack of post-translational modification machinery in bacteria, recombinant eukaryotic protein production poses an immense challenge, which invariably leads to the production of biologically in-active protein in this host. A number of techniques are cited in the literature, which describe the conversion of inactive protein, expressed as an insoluble fraction, into a soluble and active form. Overall, we have divided these methods into three major groups: Group-I, where the factors influencing the formation of insoluble fraction are modified through a stringent control of the cellular milieu, thereby leading to the expression of recombinant protein as soluble moiety; Group-II, where protein is refolded from the inclusion bodies and thereby target protein modification is avoided; Group-III, where the target protein is engineered to achieve soluble expression through fusion protein technology. Even within the same family of proteins (e.g., tyrosine kinases), optimization of standard operating protocol (SOP) may still be required for each protein's over-production at a pilot-scale in Escherichia coli. However, once standardized, this procedure can be made amenable to the industrial production for that particular protein with minimum alterations.
Collapse
Affiliation(s)
- Sudhir Sahdev
- Department of Biotechnology & Bioinformatics, New Drug Discovery Research, Ranbaxy Research Laboratories-R&D-3, 20-Sector 18 Udyog Vihar, Gurgaon, India.
| | | | | |
Collapse
|
13
|
Geng X, Wang C. Protein folding liquid chromatography and its recent developments. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 849:69-80. [PMID: 17116432 PMCID: PMC7105250 DOI: 10.1016/j.jchromb.2006.10.068] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2006] [Revised: 09/30/2006] [Accepted: 10/27/2006] [Indexed: 12/04/2022]
Abstract
The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts. However, proteins produced by Escherichia coli must be refolded to their native state. Protein folding liquid chromatography (PFLC) is a new method developed in recent years, and it is widely used in molecular biology and biotechnology. In this paper, the new method, PFLC is introduced and its recent development is reviewed. In addition the paper includes definitions, advantages, principles, applications for both laboratory and large scales, apparatus, and effecting factors of PFLC. In addition, the role of this method in the future is examined.
Collapse
Affiliation(s)
- Xindu Geng
- Institute of Modern Separation Science, Key Laboratory of Separation Science in Shaanxi Province, Northwest University, Xi'an 710069, PR China.
| | | |
Collapse
|